Tournament: Kentucky | Round: 2 | Opponent: Durham BG | Judge: Matthew Slencsak
The US handled COVID terribly – it put the whole world at risk for potential attacks, due to their poor reaction time to solving the pandemic.
Tanya Lewis, 3-11-2021, "How the U.S. Pandemic Response Went Wrong—and What Went Right—during a Year of COVID," Scientific American, https://www.scientificamerican.com/article/how-the-u-s-pandemic-response-went-wrong-and-what-went-right-during-a-year-of-covid/
When the World Health Organization first called COVID-19 a pandemic on March 11
AND
MI5, with responsibility for safeguarding the facilities in the U.K.
====Avedissian 02====
Avedissian, Grace K (J.D. Candidate, May 2003, American University, Washington College of Law; B.A., Political Science, 1997, Rutgers College). "Global Implications of a Potential U.S. Policy Shift Toward Compulsory Licensing of Medical Inventions in a New Era of "Super-Terrorism"." American University International Law Review 18, no. 1 (2002): 237-294.
Compulsory licensing is an essential legal and legislative tool in the fight against global super
AND
the TRIPS Agreement by exerting economic and political pressure on developing countries.262
COVID has proven how to solve for a bioterrorism attack – vaccination is the most important thing and making sure everyone can get access to it.
Regan F Lyon, 7-1-2021, "COVID-19 Response Has Uncovered and Increased Our Vulnerability to Biological Warfare," OUP Academic, https://academic.oup.com/milmed/article/186/7-8/193/6135020 - Harker PG
The 2018 National Biodefense Strategy (NBS) articulated a collaborative plan to prevent,
AND
defense strategies, and offer areas for improvement to restore our bioterror security.
Companies reducing IP protections are key for everyone to get access to drugs and vaccines – especially in low income countries.
~Sean, Magic and Hope: Relaxing Trips-Plus Provisions to Promote Access to Affordable Pharmaceuticals. Boston College Journal of Law and Social Justice, 33(1), 107-145, 2013, http://lawdigitalcommons.bc.edu/jlsj/vol33/iss1/4, accessed 7-31-21 Boston College of Law~
TRIPS-Plus provisions in U.S. FTAs impede access to pharmaceuticals for
AND
relaxing data exclu- sivity and compulsory licensing provisions for various drugs.207
Bioterror is possible and an existential risk – outweighs nuke war
====Von Hippel 17 ====
Frank Von Hippel, Professor of Public and International Affairs at the Woodrow Wilson School of Public and International Affairs, former assistant director for national security in the White House Office of Science and Technology, Ph.D. in Physics from Oxford University ("Bioweapons Then and Now," Nuclear Futures Lab @ Princeton University, February 19th, https://nuclearfutures.princeton.edu/wws353-2017-blog-week03-1/)
"Bioterrorism could kill more than nuclear war – but no one is ready to
AND
terrorism, of which Bill Gates claims governments have not seriously considered yet.
The aff solves – most credible studies agree CL with bioterrorism are key and the only option.
JOUR AU - Oriola, Taiwo PY , 2007/01/01, Against the plague: pharmaceutical patents exemption right as a biosecurity strategy
This Article proposes the inclusion of a bioterrorism-specific pharmaceutical patents appropriation clause in national and international patent regimes. The thesis is predicated on the impropriety of the current bureaucracy-prone access to medicines paradigms in international and national patent regimes for bioterrorism-induced public health crises situations. Using highly plausible, worst-case scenarios of bioterrorism attacks, this Article argues that vast swathes of the population could become simultaneously vulnerable to deadly bioweapons, exposing millions of people to inevitable deaths, in override patents on crucial drugs or vaccines without the consent of patent 426. Audrey R. Chapman, Approaching Intellectual Property as a Human Right: Obligations Related to Article 15 (1) (c), COPYRIGHT BULL., July-Sept. 2001, at 4, 6-7, http://unesdoc.unesco.org/images/0012/ 001255/125505e.pdf~#page=4. 427. See PERELMAN, supra note 219 at 2-3 (acquiescing to the creativity promotion rationale for intellectual property protection, but railing at the regime's degeneration into a system which now "threatens to exhaust creative activity"). 428. Lawrence O. Gostin, When Terrorism Threatens Health: How Far Are Limitations on Human Rights Justified?, 55 FLA. L. REV. 1105, 1168 (2003) 429. LAWRENCE O. GOSTIN, PUBLIC HEALTH LAW: POWER, DUTY, RESTRAINT 20 (2000). 430. George G. Djolov, Patents, Price Controls, and Pharmaceuticals: Considerations from Political Economy, 6 J. WORLD INTELL. PROP. 611, 611-31 (2003); James Thuo Gathii, Rights, Patents, Markets and the Global Aids Pandemic, 14 FLA. J. INT'L L. 261, 263-351 (2002); Faizel Ismail, The Doha Declaration on Trips and Public Health and the Negotiations in the WTO on Paragraph 6: Why PhRMA Needs to Join the Consensus!, 6 J. WORLD INTELL. PROP. 393, 393-401 (2003); Nadia Natasha Seeratan, The Negative Impact of Intellectual Property Patents Rights on Developing Countries: An Examination of the Indian Pharmaceutical Industry, 3 SCHOLAR 339, 339 (2001). No. 2~ AGAINST THE PLAGUE 343 holders, thus avoiding lengthy ight be destined for failure. Moreover, this Article deems a bioterrorism-specific appropriation clause in global negotiations that patents regimes expedient, in light of the pervasive and dominant propatents forces intent on a stronger intellectual property regime. This regime rationalizes patent protection solely on utilitarianism, and would cast attempts at proportionality of rights as campaigns against innovation.
A fortiori, absent a bioterrorism-specific pharmaceutical patent appropriation clause, authorities
AND
grounds, overriding public interests, and fundamental rights to health and life.
It solves reducing IP protections is k2 innovation and production of medicines in low-income countries
Chao and Mody 15
Tiffany Chao and Gita Mody, March 5 2015 "The impact of intellectual property regulation on global medical technology innovation" https://innovations.bmj.com/content/1/2/49
Technology innovation has the potential to expand equitable healthcare to underserved populations in global health
AND
product, which can be significant in a highly cost-sensitive market.